Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Director | March 15, 2004 | March 17, 2004 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date March 15, 2004 · Filed March 17, 2004
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Common StockSEC Table I · non-derivative | Direct | 1,643 |
Reported balance
After 2004-03-15 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2004-03-15 · Grant · Acquired 1,643 · Balance 1,643 F1: (DIR 03.15.04) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. |
| NQSO (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $59.48 · Expires 2011-03-15 | Direct | 5,000 |
Reported balance
After 2004-03-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2004-03-15 · Grant · Acquired 5,000 · Balance 5,000 |
| Common StockSEC Table I · non-derivative | Direct | 149,343 |
Reported balance
Holding disclosure · report date 2004-03-15 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 149,343 |
Filing footnotes · ownership attribution and instrument terms
F1: (DIR 03.15.04) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2004 Filed Mar 17, 2004 16:51 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016116 · rrd36764.xml · derivative · entry 3 LAZARUS STEVEN · CIK 0001054117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 17, 2004 16:51 UTC | AMGEN INC AMGN · Entity 2832 | GrantRestricted Common Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-016116 · rrd36764.xml · nonDerivative · entry 2 LAZARUS STEVEN · CIK 0001054117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 F1 · security: (DIR 03.15.04) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| February 25, 2004 Filed Feb 26, 2004 18:41 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,000 | $64.22 | $642,200.00 |
DisclosureSEC source: 0001181431-04-012078 · rrd34631.xml · nonDerivative · entry 1 LAZARUS STEVEN · CIK 0001054117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,343 Read SEC document |
| February 24, 2004 Filed Feb 25, 2004 18:05 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 8,668 | $64.00 | $554,752.00 |
DisclosureSEC source: 0001181431-04-011821 · rrd34493.xml · nonDerivative · entry 4 LAZARUS STEVEN · CIK 0001054117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,343 Read SEC document |
| February 24, 2004 Filed Feb 25, 2004 18:05 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 500 | $64.01 | $32,005.00 |
DisclosureSEC source: 0001181431-04-011821 · rrd34493.xml · nonDerivative · entry 3 LAZARUS STEVEN · CIK 0001054117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,011 Read SEC document |
| February 24, 2004 Filed Feb 25, 2004 18:05 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 332 | $64.08 | $21,274.56 |
DisclosureSEC source: 0001181431-04-011821 · rrd34493.xml · nonDerivative · entry 2 LAZARUS STEVEN · CIK 0001054117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,511 Read SEC document |
| February 24, 2004 Filed Feb 25, 2004 18:05 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 500 | $64.11 | $32,055.00 |
DisclosureSEC source: 0001181431-04-011821 · rrd34493.xml · nonDerivative · entry 1 LAZARUS STEVEN · CIK 0001054117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,843 Read SEC document |
| November 21, 2003 Filed Nov 24, 2003 20:39 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-032629 · rrd23602.xml · nonDerivative · entry 1 LAZARUS STEVEN · CIK 0001054117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,343 Read SEC document |
| September 08, 2003 Filed Sep 9, 2003 15:34 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 9,000 | $68.00 | $612,000.00 |
DisclosureSEC source: 0001181431-03-022343 · rrd18012.xml · nonDerivative · entry 1 LAZARUS STEVEN · CIK 0001054117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,343 Read SEC document |
| September 03, 2003 Filed Sep 4, 2003 17:02 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,000 | $68.11 | $68,105.00 |
DisclosureSEC source: 0001181431-03-021802 · rrd17703.xml · nonDerivative · entry 1 LAZARUS STEVEN · CIK 0001054117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,343 Read SEC document |
| August 28, 2003 Filed Sep 2, 2003 19:26 UTC Amendment | AMGEN INC AMGN · Entity 2832 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-021330 · rrd17383.xml · nonDerivative · entry 1 LAZARUS STEVEN · CIK 0001054117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,343 F1 · date: On August 28, 2003, reporting person became aware that the reporting person mistakenly filed a Form 4 on August 14, 2003 reporting a sale of 10,000 shares of common stock that did not accur. As of August 28, 2003, the reporting person owned 189,343 shares of common stock. (Note: Responses to Columns 2,3 and 4 of Table 1 are only for the purpose of accommodating the EDGAR system.) F1 · kind: On August 28, 2003, reporting person became aware that the reporting person mistakenly filed a Form 4 on August 14, 2003 reporting a sale of 10,000 shares of common stock that did not accur. As of August 28, 2003, the reporting person owned 189,343 shares of common stock. (Note: Responses to Columns 2,3 and 4 of Table 1 are only for the purpose of accommodating the EDGAR system.) F1 · shares: On August 28, 2003, reporting person became aware that the reporting person mistakenly filed a Form 4 on August 14, 2003 reporting a sale of 10,000 shares of common stock that did not accur. As of August 28, 2003, the reporting person owned 189,343 shares of common stock. (Note: Responses to Columns 2,3 and 4 of Table 1 are only for the purpose of accommodating the EDGAR system.) F1 · price: On August 28, 2003, reporting person became aware that the reporting person mistakenly filed a Form 4 on August 14, 2003 reporting a sale of 10,000 shares of common stock that did not accur. As of August 28, 2003, the reporting person owned 189,343 shares of common stock. (Note: Responses to Columns 2,3 and 4 of Table 1 are only for the purpose of accommodating the EDGAR system.) F1 · acquired: On August 28, 2003, reporting person became aware that the reporting person mistakenly filed a Form 4 on August 14, 2003 reporting a sale of 10,000 shares of common stock that did not accur. As of August 28, 2003, the reporting person owned 189,343 shares of common stock. (Note: Responses to Columns 2,3 and 4 of Table 1 are only for the purpose of accommodating the EDGAR system.) F1 · balance_after: On August 28, 2003, reporting person became aware that the reporting person mistakenly filed a Form 4 on August 14, 2003 reporting a sale of 10,000 shares of common stock that did not accur. As of August 28, 2003, the reporting person owned 189,343 shares of common stock. (Note: Responses to Columns 2,3 and 4 of Table 1 are only for the purpose of accommodating the EDGAR system.) Read SEC document |
| August 12, 2003 Filed Aug 14, 2003 16:38 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,000 | $68.00 | $680,000.00 |
DisclosureSEC source: 0001181431-03-018687 · rrd16003.xml · nonDerivative · entry 1 LAZARUS STEVEN · CIK 0001054117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,343 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.